This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (181)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Cognitive Therapy  • Depression  • Psychopharmacology  • Public Health  • Alert me on articles by topic  Social Bookmarking   What's this?

Sharon M. Hall, PhD; Victor I. Reus, MD; Ricardo F. Muñoz, PhD; Karen L. Sees, DO; Gary Humfleet, PhD; Diane T. Hartz, MA; Sydney Frederick, PhD; Elisa Triffleman, MD

Arch Gen Psychiatry. 1998;55:683-690.

Background  A history of major depressive disorder (MDD) predicts failure to quit smoking. We determined the effect of nortriptyline hydrochloride and cognitive-behavioral therapy on smoking treatment outcome in smokers with a history of MDD. The study also addressed the effects of diagnosis and treatment condition on dysphoria after quitting smoking and the effects of dysphoria on abstinence.

Methods  This was a 2 (nortriptyline vs placebo) x 2 (cognitive-behavioral therapy vs control) x 2 (history of MDD vs no history) randomized trial. The participants were 199 cigarette smokers. The outcome measures were biologically verified abstinence from cigarettes at weeks 12, 24, 38, and 64. Mood, withdrawal, and depression were measured at 3, 5, and 8 days after the smoking quit date.

Results  Nortriptyline produced higher abstinence rates than placebo, independent of depression history. Cognitive-behavioral therapy was more effective for participants with a history of depression. Nortriptyline alleviated a negative affect occurring after smoking cessation. Increases in the level of negative affect from baseline to 3 days after the smoking quit date predicted abstinence at later assessments for MDD history–negative smokers. There was also a sex-by-depression history interaction; MDD history–positive women were less likely to be abstinent than MDD history–negative women, but depression history did not predict abstinence for men.

Conclusions  Nortriptyline is a promising adjunct for smoking cessation. Smokers with a history of depression are aided by more intensive psychosocial treatments. Mood and diagnosis interact to predict relapse. Increases in negative affect after quitting smoking are attenuated by nortriptyline.

From the Department of Psychiatry University of California, San Francisco (Drs Hall, Reus, Muñoz, Sees, Humfleet, Frederick, and Triffleman and Ms Hartz); and the San Francisco Veterans Affairs Medical Center Psychiatry Service, San Francisco (Drs Hall, Sees, and Triffleman). Dr Triffleman is now at the Department of Psychiatry, Yale University, New Haven, Conn.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Psychiatry and Cigarettes
Alexander H. Glassman
Arch Gen Psychiatry. 1998;55(8):692-693.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Smoking cessation pharmacotherapy
Frishman
Ther Adv Cardiovasc Dis 2009;3:287-308.
ABSTRACT  

Smoking and depression: is smoking cessation effective?
Ischaki and Gratziou
Ther Adv Respir Dis 2009;3:31-38.
ABSTRACT  

Smoking Behavior Postmyocardial Infarction Among ENRICHD Trial Participants: Cognitive Behavior Therapy Intervention for Depression and Low Perceived Social Support Compared With Care as Usual
Trockel et al.
Psychosom. Med. 2008;70:875-882.
ABSTRACT | FULL TEXT  

Influence of Neuronal Nicotinic Receptors over Nicotine Addiction and Withdrawal
De Biasi and Salas
Exp. Biol. Med. 2008;233:917-929.
ABSTRACT | FULL TEXT  

Nortriptyline plus nicotine replacement versus placebo plus nicotine replacement for smoking cessation: pragmatic randomised controlled trial
Aveyard et al.
BMJ 2008;336:1223-1227.
ABSTRACT | FULL TEXT  

References
APPI Online CME 2007;2007:2-2.
FULL TEXT  

Addressing Nicotine Dependence in Psychodynamic Psychotherapy: Perspectives From Residency Training
Prochaska et al.
Acad. Psychiatry 2007;31:8-14.
ABSTRACT | FULL TEXT  

The influence of tobacco smoke and nicotine on antidepressant and memory-improving effects of venlafaxine
Nowakowska et al.
Hum Exp Toxicol 2006;25:199-209.
ABSTRACT  

Efficacy of Bupropion and Nortriptyline for Smoking Cessation Among People at Risk for or With Chronic Obstructive Pulmonary Disease
Wagena et al.
Arch Intern Med 2005;165:2286-2292.
ABSTRACT | FULL TEXT  

Pharmacotherapy for Nicotine Dependence
Henningfield et al.
CA Cancer J Clin 2005;55:281-299.
ABSTRACT | FULL TEXT  

Improving the Rates of Quitting Smoking for Veterans With Posttraumatic Stress Disorder
McFall et al.
Am. J. Psychiatry 2005;162:1311-1319.
ABSTRACT | FULL TEXT  

Organ Transplantation
DiMartini et al.
Focus 2005;3:280-303.
FULL TEXT  

Extended Nortriptyline and Psychological Treatment for Cigarette Smoking
Hall et al.
Am. J. Psychiatry 2004;161:2100-2107.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

What's "Unstable" in Unstable Angina?
Ketterer et al.
Psychosomatics 2004;45:185-196.
ABSTRACT | FULL TEXT  

Quality of life following lung cancer surgery
Myrdal et al.
Thorax 2003;58:194-197.
ABSTRACT | FULL TEXT  

A Randomized Trial of Sertraline as a Cessation Aid for Smokers With a History of Major Depression
Covey et al.
Am. J. Psychiatry 2002;159:1731-1737.
ABSTRACT | FULL TEXT  

Psychological Intervention and Antidepressant Treatment in Smoking Cessation
Hall et al.
Arch Gen Psychiatry 2002;59:930-936.
ABSTRACT | FULL TEXT  

Smoking Cessation Approaches for Persons With Mental Illness or Addictive Disorders
el-Guebaly et al.
Psychiatr. Serv. 2002;53:1166-1170.
ABSTRACT | FULL TEXT  

Pharmacologic Therapy for Nicotine Addiction
DeGraff
Chest 2002;122:392-394.
FULL TEXT  

Stopping Smoking* : A Prospective, Randomized, Double-Blind Study Comparing Nortriptyline to Placebo
da Costa et al.
Chest 2002;122:403-408.
ABSTRACT | FULL TEXT  

Treatment of Tobacco Use and Dependence
Rigotti
NEJM 2002;346:506-512.
FULL TEXT  

Behavioral Tobacco Cessation Treatments: Yesterday's News or Tomorrow's Headlines?
Brandon
JCO 2001;19:64s-68.
ABSTRACT | FULL TEXT  

Antidepressants in the treatment of patients with COPD: possible associations between smoking cigarettes, COPD and depression
WAGENA et al.
Thorax 2001;56:587a-588.
FULL TEXT  

Update in Addiction Medicine
Schneider et al.
ANN INTERN MED 2001;134:387-395.
FULL TEXT  

A 36-Year-Old Woman Who Smokes Cigarettes
Rigotti
JAMA 2000;284:741-749.
FULL TEXT  

Development of Major Depression After Treatment for Smoking Cessation
Tsoh et al.
Am. J. Psychiatry 2000;157:368-374.
ABSTRACT | FULL TEXT  

Antidepressants and Smoking Cessation
Gambassi et al.
Arch Intern Med 1999;159:1257-1258.
FULL TEXT  

Other articles noted
Evid. Based Ment. Health 1999;2:8-8.
FULL TEXT  

Psychiatry and Cigarettes
Glassman
Arch Gen Psychiatry 1998;55:692-693.
FULL TEXT